RIBOLIFE-B Maintains 170.55 Million Issued Shares in April; Confirms Public Float Compliance

Bulletin Express05-07

Suzhou Ribo Life Science Co., Ltd. (RIBOLIFE-B) filed its Monthly Return for the period ended 30 April 2026, showing no changes in share capital structure.

Authorised and Issued Share Capital • Authorised/registered capital and issued shares both closed the month unchanged at 170.55 million ordinary H-shares with a par value of RMB1.00 each, equal to RMB170.55 million in registered share capital. • No treasury shares were held or cancelled during the period.

Public Float Status • The company reconfirmed compliance with the Hong Kong Main Board’s minimum public float requirement. The threshold set at listing was 15.61 % of issued H-shares (excluding treasury shares).

Equity Incentives • 2.11 million share options remain outstanding under the Pre-IPO Share Option Scheme, carrying an exercise price of RMB3.70 per share. • No options vested or were exercised in April; the earliest vesting date is 9 January 2028.

Other Capital Movements • The issuer reported no warrants, convertibles, additional option arrangements, or other share movements for the month.

Governance Confirmation • The submission was signed by Joint Company Secretary Mr. Zhang Su, affirming adherence to all applicable listing rules and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1109213236?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-07 17:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109213236","market":"us","top_or_hot":-1,"title":"RIBOLIFE-B Maintains 170.55 Million Issued Shares in April; Confirms Public Float Compliance","media":"Bulletin Express","content":"<p>Suzhou Ribo Life Science Co., Ltd. (RIBOLIFE-B) filed its Monthly Return for the period ended 30 April 2026, showing no changes in share capital structure.</p>\n<p>Authorised and Issued Share Capital  \n• Authorised/registered capital and issued shares both closed the month unchanged at 170.55 million ordinary H-shares with a par value of RMB1.00 each, equal to RMB170.55 million in registered share capital.  \n• No treasury shares were held or cancelled during the period.</p>\n<p>Public Float Status  \n• The company reconfirmed compliance with the Hong Kong Main Board’s minimum public float requirement. The threshold set at listing was 15.61 % of issued H-shares (excluding treasury shares).</p>\n<p>Equity Incentives  \n• 2.11 million share options remain outstanding under the Pre-IPO Share Option Scheme, carrying an exercise price of RMB3.70 per share.  \n• No options vested or were exercised in April; the earliest vesting date is 9 January 2028.</p>\n<p>Other Capital Movements  \n• The issuer reported no warrants, convertibles, additional option arrangements, or other share movements for the month.</p>\n<p>Governance Confirmation  \n• The submission was signed by Joint Company Secretary Mr. Zhang Su, affirming adherence to all applicable listing rules and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RIBOLIFE-B Maintains 170.55 Million Issued Shares in April; Confirms Public Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRIBOLIFE-B Maintains 170.55 Million Issued Shares in April; Confirms Public Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-07 17:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Suzhou Ribo Life Science Co., Ltd. (RIBOLIFE-B) filed its Monthly Return for the period ended 30 April 2026, showing no changes in share capital structure.</p>\n<p>Authorised and Issued Share Capital  \n• Authorised/registered capital and issued shares both closed the month unchanged at 170.55 million ordinary H-shares with a par value of RMB1.00 each, equal to RMB170.55 million in registered share capital.  \n• No treasury shares were held or cancelled during the period.</p>\n<p>Public Float Status  \n• The company reconfirmed compliance with the Hong Kong Main Board’s minimum public float requirement. The threshold set at listing was 15.61 % of issued H-shares (excluding treasury shares).</p>\n<p>Equity Incentives  \n• 2.11 million share options remain outstanding under the Pre-IPO Share Option Scheme, carrying an exercise price of RMB3.70 per share.  \n• No options vested or were exercised in April; the earliest vesting date is 9 January 2028.</p>\n<p>Other Capital Movements  \n• The issuer reported no warrants, convertibles, additional option arrangements, or other share movements for the month.</p>\n<p>Governance Confirmation  \n• The submission was signed by Joint Company Secretary Mr. Zhang Su, affirming adherence to all applicable listing rules and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06938","symbol_name":"瑞博生物-B","start_time":0,"source_url":"","article_id":"1109213236","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109213236","pubTimestamp":1778145801,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Suzhou Ribo Life Science Co., Ltd. (RIBOLIFE-B) filed its Monthly Return for the period ended 30 April 2026, showing no changes in share capital structure. Authorised and Issued Share Capital   •...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06938":"瑞博生物-B"},"translate_title":"Ribolife-B 4月份维持1.7055亿股已发行股份；确认公众持股量合规","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06938":1},"content_text":"Suzhou Ribo Life Science Co., Ltd. (RIBOLIFE-B) filed its Monthly Return for the period ended 30 April 2026, showing no changes in share capital structure.\nAuthorised and Issued Share Capital  \n• Authorised/registered capital and issued shares both closed the month unchanged at 170.55 million ordinary H-shares with a par value of RMB1.00 each, equal to RMB170.55 million in registered share capital.  \n• No treasury shares were held or cancelled during the period.\nPublic Float Status  \n• The company reconfirmed compliance with the Hong Kong Main Board’s minimum public float requirement. The threshold set at listing was 15.61 % of issued H-shares (excluding treasury shares).\nEquity Incentives  \n• 2.11 million share options remain outstanding under the Pre-IPO Share Option Scheme, carrying an exercise price of RMB3.70 per share.  \n• No options vested or were exercised in April; the earliest vesting date is 9 January 2028.\nOther Capital Movements  \n• The issuer reported no warrants, convertibles, additional option arrangements, or other share movements for the month.\nGovernance Confirmation  \n• The submission was signed by Joint Company Secretary Mr. Zhang Su, affirming adherence to all applicable listing rules and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1109213236","isCrawlerRequest":true}